Quantinno Capital Management LP Increases Position in Kenvue Inc. $KVUE

Quantinno Capital Management LP boosted its position in Kenvue Inc. (NYSE:KVUE) by 59.5% during the first quarter, Holdings Channel reports. The fund owned 1,345,956 shares of the company’s stock after acquiring an additional 502,024 shares during the period. Quantinno Capital Management LP’s holdings in Kenvue were worth $23,204,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Montag A & Associates Inc. lifted its stake in Kenvue by 6.3% during the first quarter. Montag A & Associates Inc. now owns 10,156 shares of the company’s stock worth $175,000 after purchasing an additional 600 shares during the last quarter. Cornerstone Wealth Group LLC boosted its holdings in shares of Kenvue by 5.9% in the 1st quarter. Cornerstone Wealth Group LLC now owns 10,810 shares of the company’s stock worth $187,000 after purchasing an additional 606 shares in the last quarter. Physician Wealth Advisors Inc. increased its position in shares of Kenvue by 67.5% during the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after purchasing an additional 618 shares during the last quarter. Mill Creek Capital Advisors LLC increased its position in shares of Kenvue by 0.6% during the 4th quarter. Mill Creek Capital Advisors LLC now owns 124,213 shares of the company’s stock valued at $2,143,000 after purchasing an additional 701 shares during the last quarter. Finally, B & T Capital Management DBA Alpha Capital Management increased its position in shares of Kenvue by 0.3% during the 4th quarter. B & T Capital Management DBA Alpha Capital Management now owns 234,664 shares of the company’s stock valued at $4,048,000 after purchasing an additional 712 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.59% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on KVUE shares. UBS Group boosted their target price on Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research report on Thursday, July 16th. Wall Street Zen upgraded shares of Kenvue to a “buy” rating in a research report on Sunday, July 12th. Zacks Research downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Weiss Ratings upgraded shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Finally, Barclays upped their price objective on shares of Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 21st. Three equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $19.58.

Kenvue Trading Down 0.3%

NYSE KVUE opened at $19.25 on Friday. The firm has a market cap of $36.95 billion, a PE ratio of 22.64, a price-to-earnings-growth ratio of 1.46 and a beta of 0.47. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $22.28. The stock has a 50-day moving average of $18.59 and a 200-day moving average of $18.01. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.05. The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.Kenvue’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period last year, the company earned $0.24 EPS. As a group, sell-side analysts forecast that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 12th will be paid a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.4%. This is a boost from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Wednesday, August 12th. Kenvue’s payout ratio is currently 98.82%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.